Complementary and alternative medications consumed by patients with head and neck carcinoma: A pilot study in Germany

Nutrition and Cancer

Volumn 64, Issue 3, 2012, Pages 377-385

  Schultz, J D ^a   Stegmller, M ^b   Faber, A ^a   Thorn, C ^a   Hrmann, K ^a   Nowack, R ^c   Sauter, A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Centre for Nephrology and Dialysis Lindau/Bodensee   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; FORMIC ACID; GLUCOSAMINE; MELATONIN; MINERAL; OMEGA 3 FATTY ACID; PROBIOTIC AGENT; VITAMIN;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER PATIENT; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; FATIGUE; FEMALE; GERMANY; HEAD AND NECK CARCINOMA; HERB TEA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; PHYTOTHERAPY; PILOT STUDY; QUESTIONNAIRE; SEX DIFFERENCE; SPIRULINA; TEA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICRONUTRIENTS; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PREVALENCE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84859743159     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.655400     Document Type: Article

References (56)

1. Ernst, E, and, Cassileth, B R. 1998. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer, 83: 777-782. (Pubitemid 28387704)
2. Kelly, K M. 2007. Complementary and alternative medicines for use in supportive care in pediatric cancer. Support Care Cancer, 15: 457-460. (Pubitemid 46697016)
3. Cui, Y, Shu, X O, Gao, Y, Wen, W, Ruan, ZX. 2004. Use of complementary, alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat, 85: 263-270. (Pubitemid 38987261)
4. Navo, M A, Phan, J, Vaughan, C, Palmer, JL, Michaud, L. 2004. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol, 22: 671-677. (Pubitemid 41095070)
5. Adler, S R. 1999. Complementary and alternative medicine use among women with breast cancer. Med Anthropol Q, 13: 214-222.
6. National Center for Complementary and Alternative Medicine. Biologically based practices: an overview. Available at
7. Eisenberg, D M, Kessler, R C, Van Rompay, M I, Kaptchuk, TJ, Wilkey, SA. 2001. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med, 135: 344-351. (Pubitemid 32823241)
8. Astin, J A, Marie, A, Pelletier, K R, Hansen, E, and, Haskell, W L. 1998. A review of the incorporation of complementary, alternative medicine by mainstream physicians. Arch Intern Med, 158: 2303-2310. (Pubitemid 28536483)
9. Tagliaferri, M, Cohen, I, and, Tripathy, D. 2001. Complementary and alternative medicine in early-stage breast cancer. Semin Oncol, 28: 121-134. (Pubitemid 32172414)
10. Guo, R, Canter, P H, and, Ernst, E. 2007. A systematic review of randomised clinical trials of individualised herbal medicine in any indication. Postgrad Med J, 83: 633-637. (Pubitemid 350032618)
11. Sparreboom, A, Cox, M C, Acharya, M R, and, Figg, W D. 2004. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol, 22: 2489-2503. (Pubitemid 41115408)
12. Markman, M. 2002. Safety issues in using complementary and alternative medicine. J Clin Oncol, 20: 39S-41S.
13. Kovacs, E. 2002. The in vitro effect of Viscum album (VA) extract on DNA repair of peripheral blood mononuclear cells (PBMC) in cancer patients. Phytother Res, 16: 143-147. (Pubitemid 34297457)
14. Gabius, S, and, Gabius, H J. 2002. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks]. Dtsch Med Wochenschr, 127: 457-459. (Pubitemid 34194723)
15. Risberg, T, Vickers, A, Bremnes, R M, Wist, E A, Kaasa, S. 2003. Does use of alternative medicine predict survival from cancer?. Eur J Cancer, 39: 372-377. (Pubitemid 36140056)
16. Rakovitch, E, Pignol, J P, Chartier, C, Ezer, M, Verma, S. 2005. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat, 90: 139-148. (Pubitemid 40568897)
17. Meijerman, I, Beijnen, J H, and, Schellens, J H. 2006. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist, 11: 742-752. (Pubitemid 44157562)
18. Kennedy, D D, Tucker, K L, Ladas, E D, Rheingold, S R, Blumberg, J. 2004. Lowantioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr, 79: 1029-1036. (Pubitemid 41095955)
19. Kennedy, D D, Ladas, E J, Rheingold, S R, Blumberg, J, Kelly, K M. 2005. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer, 44: 378-385. (Pubitemid 40316031)
20. Aquino, V M, Harvey, A R, Garvin, J H, Godder, K T, Nieder, M L. 2005. A double-blind, randomized, placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant, 36: 611-616. (Pubitemid 43115017)
21. Anderson, P M, Ramsay, N K, and, Shu, X O. 1998. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant, 22: 339-344. (Pubitemid 28401073)
22. Willetts, K E, Ekangaki, A, and, Eden, J A. 2003. Effect of a ginger extract on pregnancy-induced nausea: a randomised controlled trial. Aust N Z J Obstet Gynaecol, 43: 139-144. (Pubitemid 36626118)
23. Manusirivithaya, S, Sripramote, M, Tangjitgamol, S, Sheanakul, C, Leelahakorn, S. 2004. Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin. Int J Gynecol Cancer, 14: 1063-1069. (Pubitemid 39603348)
24. Tagliaferri, M, Cohen, I, and, Tripathy, D. 2001. Complementary and alternative medicine in early-stage breast cancer. Semin Oncol, 28: 121-134. (Pubitemid 32172414)
25. Kelly, K M, Jacobson, J S, Kennedy, D D, Braudt, S M, Mallick, M. 2000. Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol, 22: 412-416. (Pubitemid 33599747)
26. Nowack, R, Ballé, C, Birnkammer, F, Koch, W, Sessler, R. 2009. Complementary and Alternative Medications consumed by renal patients in southern Germany. J Renal Nutr, 19: 211-229.
27. Tindle, H A, Davis, R B, Philips, R S, and, Eisenberg, D M. 2005. Trends in use of complementary and alternative medicine by U.S. adults. Altern Ther Health Med, 11: 42-49. (Pubitemid 40110627)
28. Di Bella Study Group. 1999. Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trails. BMJ, 318: 224-228.
29. Zemskov, S V, Prokopchuk, O L, and, Susak, Y M. 2000. Ukrain treatment in a patient with breast carcinoma case report. Drugs Exp Clin Res, 26: 253-254. (Pubitemid 32373351)
30. Sparreboom, A, Cox, M C, Acharya, M R, and, Figg, W D. 2004. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol, 22: 2489-2503. (Pubitemid 41115408)
31. Markman, M. 2004. Safety issues in using complementary and alternative medicine. J Clin Oncol, 20: 4810-4815.
32. Rakovitch, E, Pignol, J P, Chartier, C, Ezer, M, Verma, S. 2005. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat, 90: 139-148. (Pubitemid 40568897)
33. Broxterman, H J, Lankelma, J, and, Hoekman, K. 2003. Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences. Drug Resist Updat, 6: 111-127. (Pubitemid 36890336)
34. Zhou, S, Chan, E, Pan, S Q, Huang, M, and, Lee, E J. 2004. Pharmacokinetic interactions of drugs with St John's wort. J Psychopharmacol, 18: 262-276. (Pubitemid 38954916)
35. Izzo, A A, and, Ernst, E. 2001. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs, 61: 2163-2175. (Pubitemid 34074799)
36. Zhou, S, Koh, H L, Gao, Y, Gong, Z Y, and, Lee, E J. 2004. Herbal bioactivation: the good, the bad and the ugly. Life Sci, 74: 935-968. (Pubitemid 37522131)
37. Rockwell, S, Liu, Y, and, Higgins, S A. 2005. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat, 90: 233-239. (Pubitemid 40576836)
38. Risberg, T, Vickers, A, Bremnes, R M, Wist, E A, Kaasa, S. 2003. Does use of alternative medicine predict survival from cancer?. Eur J Cancer, 39: 372-377. (Pubitemid 36140056)
39. HemaIswarya, S, and, Doble, M. 2006. Potential synergism of natural products in the treatment of cancer. Phytother Res, 20: 239-249.
40. Silva, V, El-Metwally, A, Ernst, E, Lewith, G, and, Macfarlane, G J. 2010. Evidence for the efficacy of complentary and alternative medicines in the management of fibromyalgia: a systematic review. Rheumatology, 49: 1063-1068.
41. Coates, J R, and, Jobst, K A. 1998. Integrated healthcare: a way forward for the next five years? a discussion document from the Prince of Wales's Initiative on Integrated Medicine. J Altern Complementary Med, 4: 209-247.
42. Zollman, C, and, Vickers, A. 1999. Users and practitioners of complementary medicine. BMJ, 399: 836-838.
43. Eisenberg, D M, Kessler, R C, Foster, C, Norlock, F E, Calkins, D R. 1993. Unconventional medicine in the United States. New Engl J of Med, 328: 246-252.
44. Robert Koch Institut. 2006. Angaben zur Inzidenz und Mortalitt in BRD [Data on incidence and mortality in Federal Republic of Germany]. Retrieved from http://www.rki.de
45. Sturgis, E M, Wei, Q, and, Spitz, M R. 2004. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol, 31: 726-733. (Pubitemid 39602678)
46. Bier, H. 1994. Krebsepidemioloie: Vernderung in der Hufigkeit von bsartigen Geschwlsten des Kopf-Hals-Bereiches [Epidemiology of Cancer. Changes in incidence of malignant tumors in the head and neck area]. HNO, 42: 390-392.
47. Sarris, J, and, Byrne, G J. 2011. A systematic review of insomnia and complementary medicine. Sleep Med Rev, 15: 99-106.
48. Avlonitou, E, Kapsimalis, F, Varouchakis, G, Vardavas, C I, and, Behrakis, P. 2011. Adherence to CPAP therapy improves quality of life and reduces symptoms among obstructive sleep apne syndrome patients. Sleep Breath,. [Epub ahead of print]
49. Servaes, J, Verhagen, S, and, Bleijenberg, G. 2002. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol, 13: 589-598. (Pubitemid 34461143)
50. Cui, Y, Shu, X O, Gao, Y, Wen, W, Ruan, Z X. 2004. Use of complementary, alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat, 85: 263-270. (Pubitemid 38987261)
51. Navo, M A, Phan, J, Vaughan, C, Palmer, JL, Michaud, L. 2004. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol, 22: 671-677. (Pubitemid 41095070)
52. Adler, S R. 1999. Complementary and alternative medicine use among women with breast cancer. Med Anthropol Q, 13: 214-222.
53. Metz, J M, Jones, H, Devine, P, Hahn, S, and, Glatstein, E. 2001. Cancer patients use unconventional medical therapies far more frequently than standard history, physical examination suggest. Cancer J, 7: 149-154.
54. Abramson, B, Chan, R H, and, Kwan, K. Abstract 2520. Presented at the Annual Conference of the American Heart Association. Dallas, Texas
55. Goldstein, L H, Elias, M, Ron-Avraham, G, Biniaurishvili, BZ, Madjar, M. 2007. Consumption of herbal remedies and dietary supplements among patients hospitalised in medical wards. Br J Pharmacol, 6: 373-380. (Pubitemid 47283856)
56. Canter, P H, and, Ernst, E. 2004. Herbal supplements used by persons over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors potential for negative interactions. Drug Aging, 21: 597-605. (Pubitemid 39070994)